260. Sitosterolemia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 12 / Drugs : 11 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathway : 1
Sitosterolemia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 260 | Sitosterolemia | - |
| 49 | Systemic lupus erythematosus | 1.000 |
| 79 | Homozygous familial hypercholesterolemia | 1.000 |
| 93 | Primary biliary cholangitis | 1.000 |